# Association Between Statin Use, Cytokine Storm, and Clinical Outcomes in COVID-19 Patients with Diabetes

**Authors:** Ivan Feldi, Barbara Grubišić, Tatjana Bačun, Zvonimir Bosnić, Dunja Šojat, Mario Šafer, Marko Pirić, Lada Zibar

PMC · DOI: 10.3390/biomedicines14030518 · Biomedicines · 2026-02-26

## TL;DR

This study found that statin use in diabetic patients with COVID-19 was linked to lower odds of needing mechanical ventilation, despite more cardiovascular issues.

## Contribution

The study provides new observational evidence on the potential protective effect of statins on respiratory outcomes in diabetic COVID-19 patients.

## Key findings

- Statin users had lower unadjusted IL-6 and ferritin levels but no significant differences after adjustment.
- Statin therapy was independently associated with lower odds of mechanical ventilation.
- Patients on statins had more cardiovascular comorbidities but better respiratory outcomes.

## Abstract

Objective: To examine patterns of inflammatory markers, kidney function, and clinical outcomes in patients with type 2 diabetes (T2D) hospitalized for COVID-19, with particular focus on the impact of therapy with hydroxymethylglutaryl-CoA reductase inhibitors (statins). Methods: We conducted a retrospective analysis of 440 T2D patients, divided into those who were on statin therapy prior to hospitalization and those who were not. Clinical characteristics, laboratory markers of inflammation, kidney function, and the requirement for invasive ventilation were compared between the groups. Results: Patients were predominantly older adults with a high burden of comorbidities, most commonly arterial hypertension and chronic kidney disease, and presented with elevated inflammatory markers and hyperglycemia at admission. Statin users more frequently had cardiovascular comorbidities and showed lower unadjusted interleukin-6 (IL-6) and ferritin levels, although these differences were not significant after multivariable adjustment. Importantly, statin therapy was independently associated with lower odds of mechanical ventilation in multivariable analysis. Conclusions: Despite a higher prevalence of cardiovascular comorbidities, diabetic patients receiving statins had lower odds of mechanical ventilation. No independent association with inflammatory markers was confirmed, and the observed relationship with respiratory outcomes should be interpreted cautiously given the observational design.

## Linked entities

- **Proteins:** IL6 (interleukin 6)
- **Diseases:** type 2 diabetes (MONDO:0005148), chronic kidney disease (MONDO:0005300), COVID-19 (MONDO:0100096)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** T2D (MESH:D003924), inflammation (MESH:D007249), Diabetes (MESH:D003920), COVID-19 (MESH:D000086382), chronic kidney disease (MESH:D051436), cardiovascular comorbidities (MESH:D002318), hyperglycemia (MESH:D006943), hypertension (MESH:D006973)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13024259/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024259/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC13024259/full.md

---
Source: https://tomesphere.com/paper/PMC13024259